tert-Butyl 2-formylbenzylcarbamate

Catalog No.: 
ACUCWJ459
CAS No.: 
1780989-74-3
Molecular Formula: 
C13H17NO3
Molecular Weight: 
235.28
tert-Butyl 2-formylbenzylcarbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$153.00InquiryInquiry
1g97%$447.00InquiryInquiry
5g97%$2190.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 2-formylbenzylcarbamate
IUPAC Nametert-Butyl 2-formylbenzylcarbamate
MDL No.MFCD30067393
Molecular FormulaC13H17NO3
Molecular Weight235.28
SMILESO=C(OC(C)(C)C)NCC1=CC=CC=C1C=O
InChI KeyFIRRZSOXRVOMRL-UHFFFAOYSA-N
Synonymtert-Butyl 2-formylbenzylcarbamate;Carbamic acid, N-[(2-formylphenyl)methyl]-, 1,1-dimethylethyl ester
CAS No.1780989-74-3

Safety Data

Pictogram
Health hazardEnvironmental hazardHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H302-H319-H372-H410
Precautionary Statement(s)
P260-P264-P270-P273-P280-P301+P312+P330-P305+P351+P338-P314-P337+P313-P391-P501

Synthetic Route by SureRoute

1. ACUCWJ459 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVTU012 route compound structure diagram
    ACQVTU0121333114-86-5In Stock
  2. Then
  3. ACUCWJ459 route product structure diagram
    ACUCWJ4591780989-74-3
Inquiry

2. ACUCWJ459 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOJRA543 route compound structure diagram
    ACOJRA543162356-90-3In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUCWJ459 route product structure diagram
    ACUCWJ4591780989-74-3
Inquiry

3. ACUCWJ459 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUCWJ459 route product structure diagram
    ACUCWJ4591780989-74-3
Inquiry

Comments (0)